戻る Agenda
Session 5 : New Age Pharmacovigilance- New and Emerging Therapies and Our Readiness
Session Chair(s)
Prashant Joshi, RPH
General Manager & Global Head Account Delivery, MDPS
Wipro Ltd. And Wipro Life Science (WLS), India
Pharma research has transformed significantly in past decade and is ready for the next leap with newer therapies (Cell and Gene therapy), innovative technologies (NDDS, Medical Devices etc.), path breaking personalised medicines (regenerative medicine) and use of cognitive Intelligence. And similarly, Pharmacovigilance has upgraded in past decade, however, are we ready for this exponential change the new and emerging trend would bring? The Panel of experts would discuss about the challenges we may see and changes we need to bring it to adopt quickly to this new age pharmacovigilance.
Speaker(s)
Contributing Panelist
Prashant Dhanavade
Fortrea Drug Development, India
Associate Director - Patient Safety Solutions
Contributing Panelist
Bobby George, PHD
Reliance Life Sciences, India
Vice President & Group Head Regulatory Affairs
Contributing Panelist
Dhanaraj E
Biocon, India
Pharmacovigilance Lead- CDMA-BBL
Contributing Panelist
Srikanth Jata
Pharmalex, India
Director Head of Medical Safety Activities - Pharmacovigilance